Neutralization escape of emerging subvariants XBB.1.5/1.9.1 and XBB.2.3 from current therapeutic monoclonal antibodies-Reference-Cited by-同舟云学术

Neutralization escape of emerging subvariants XBB.1.5/1.9.1 and XBB.2.3 from current therapeutic monoclonal antibodies

Published:2023-09 Issue:9 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Chye De Hoe¹,Chew Charmaine W. Y.²,Yeo He Ping²,Tambyah Paul A.³,Young Barnaby E.²⁴⁵,Tan Gladys G. Y.¹,Tan Boon Huan¹⁵,Vasoo Shawn²⁴⁵,Chan Conrad E. Z.¹²^ORCID

Affiliation:

1. DSO National Laboratories Defence Medical and Environmental Research Institute Singapore Singapore

2. National Centre for Infectious Diseases Singapore Singapore

3. Department of Medicine, Infectious Diseases Translational Research Program, Division of Infectious Diseases, National University Hospital National University of Singapore Singapore Singapore

4. Tan Tock Seng Hospital Singapore Singapore

5. Lee Kong Chian School of Medicine Nanyang Technological University Singapore Singapore

Funder

Ministry of Health -Singapore

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29074

Reference9 articles.

1. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab